1987
DOI: 10.1016/0008-8749(87)90278-4
|View full text |Cite
|
Sign up to set email alerts
|

Angiotensin II is chemotactic for a T-cell subset which can express migration inhibition factor activity in murine schistosomiasis mansoni

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
16
0
1

Year Published

1992
1992
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 33 publications
(18 citation statements)
references
References 20 publications
1
16
0
1
Order By: Relevance
“…Furthermore, Ang II may contribute to the development of an acute coronary syndrome through the migration of macrophages into a neointimal area 33 or by producing reactive oxygen species and thereby increasing oxidative stress. 34 Increased secretion of macrophage-derived interleukins was observed in cells exposed to oxidative stress, such as oxidized LDL or cellular lipid peroxidation induced by iron ions.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, Ang II may contribute to the development of an acute coronary syndrome through the migration of macrophages into a neointimal area 33 or by producing reactive oxygen species and thereby increasing oxidative stress. 34 Increased secretion of macrophage-derived interleukins was observed in cells exposed to oxidative stress, such as oxidized LDL or cellular lipid peroxidation induced by iron ions.…”
Section: Discussionmentioning
confidence: 99%
“…In addition to its effects on cardiovascular pathology such as arterial hypertension, left ventricular hypertrophy, and restenosis (Suzuki et al, 2000;Ruiz-Ortega et al, 2001;Phillips and Kagiyama, 2002), Ang II may initiate the inflammatory process (Suzuki et al, 2003). For example, Ang II contributes to the recruitment of inflammatory cells into tissue through the regulation of adhesion molecules and chemokines and by directly activating chemotaxis (Suzuki et al, 2000;Ruiz-Ortega et al, 2001;Phillips and Kagiyama, 2002;Riaz et al, 2004) in a variety of cell types including monocytes (Ni et al, 2004), vascular smooth muscle cells (Meloche et al, 2000), neonatal cardiac fibroblasts (Graf et al, 2000), retinal pericytes (Nadal et al, 2002), T cells (Weinstock et al, 1987), and neutrophils (Elferink and de Koster, 1997). A prototypical GPCR, AT 1 R signaling is generally dependent on heterotrimeric G-proteins and is known to be primarily coupled to G ␣q/11 and in some circumstances to G ␣i and G ␣o (de Gasparo et al, 2000;Touyz and Schiffrin, 2000;Berk, 2001).…”
mentioning
confidence: 99%
“…Cet enzyme a comme fonction principale d'effectuer la conversion de l'angiotensine I en angiotensine II dans le système rénine-angiotensine (Erdos, 1977), système de régulation de la pression corporelle. L'hypothèse serait que ACE aurait un effet chémotactique sur les lymphocytes T via l'angiotensine II (voir figure 2b) (Weinstock et al, 1987). Pour ce qui est des maladies cardiovasculaires, selon l'équipe de Diet , ACE serait présent dans les plaques athérosclérotiques, plus particulièrement dans la section de haute vascularisation {shoulder region) à l'endroit où on retrouve un regroupement de lymphocytes T et de macrophages, et participerait probablement à la croissance de la plaque .…”
Section: Enzyme De Conversion De Vangiotensineunclassified